ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1104

Heritability and Familial Risk of Systemic Lupus Erythematosus in Sweden: A Population-based Case-control Study

Elizabeth Arkema1, Marios Rossides 1, Christopher Sjöwall 2, Elisabet Svenungsson 3 and Julia Simard 4, 1Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden, 2Department of Clinical and Experimental Medicine, Rheumatology/Division of Neuro and Inflammation Sciences, Linköping University, Linköping, Sweden, 3Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden, 4Stanford University School of Medicine, Palo Alto, CA

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: epidemiologic methods and population studies, family studies, Inheritance, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: Epidemiology & Public Health Poster II: Spondyloarthritis & Connective Tissue Disease

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Previous studies examining the relative risk (RR) associated with having a first degree relative (FDR) with systemic lupus erythematosus (SLE) were small and few investigated different proband-relative relationships nor stratified by proband characteristics, which is likely important when studying a heterogenous disease such as SLE. Our goal was to estimate the familial RR and heritability of SLE stratified by age at onset, sex and kinship in a large population-based sample.

Methods: We conducted a case-control-family study using Swedish nationwide registers. Proband SLE cases were identified from the National Patient Register using ICD codes for SLE (≥2 visits, ≥1 in specialist care (internal medicine, pediatrics, rheumatology, dermatology, nephrology); 1971-2016; n=8801). Lupus nephritis was defined using ICD codes for lupus-related kidney disease (ICD-10 N00-N06, N16.2, N16.4, N16.8, N17-N19, N26, M32.1) Proband controls were matched to each case 5:1 on age, sex and residential location. FDRs and half siblings were identified from the Multi-Generation Register and SLE in relatives was identified the same way as for cases. Conditional logistic regression models estimated RRs for SLE associated with having an FDR with SLE. Models were stratified by age at onset, sex of the proband/relative, and lupus nephritis. Robust variance estimates were used to calculate 95% confidence intervals (95%CI) to account for correlated data. Heritability was estimated using tetrachoric correlations among first degree relatives and prevalence estimates for our population.

Results: 5% of proband cases had ≥1 relative with SLE compared to 0.5% of controls. The RR for SLE associated with having ≥1 FDR with SLE was 11.1 (95%CI 9.3, 13.3; Table). The RR was higher if ≥2 FDRs had SLE (39.8; 95%CI 14.1, 112.4) and lower if a half sibling had SLE (RR 2.6; 95%CI 0.5, 13.3). RRs were higher for SLE diagnosed at a younger age (< 18y RR 23.7; 95%CI 11.0, 53.6) and in male proband/male relative kinships (RR 32.0; 95%CI 11.3, 90.8), although this was based on small numbers. There was no considerable difference in the association when stratified by lupus nephritis status. Heritability was 61% (95%CI 58, 64).

Conclusion: Having a first degree relative with SLE is associated with an 11-fold increased risk of SLE, making it a very strong risk factor for the disease. The risk is highest for pediatric SLE and decreases with increasing age at diagnosis. There were no large differences in risk by lupus nephritis phenotype, kinship, or sex. The male proband-male relative association was the highest, although this was based on small numbers. 61% of the phenotypic variance of SLE is attributable to genetic factors.


Table for abstract 2019-06-04

Relative risk of SLE associated with having relatives diagnosed with systemic lupus erythematosus -SLE- overall and stratified by age at inclusion, sex of the proband, sex of the relative and lupus nephritis phenotype.


Disclosure: E. Arkema, None; M. Rossides, None; C. Sjöwall, None; E. Svenungsson, None; J. Simard, None.

To cite this abstract in AMA style:

Arkema E, Rossides M, Sjöwall C, Svenungsson E, Simard J. Heritability and Familial Risk of Systemic Lupus Erythematosus in Sweden: A Population-based Case-control Study [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/heritability-and-familial-risk-of-systemic-lupus-erythematosus-in-sweden-a-population-based-case-control-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/heritability-and-familial-risk-of-systemic-lupus-erythematosus-in-sweden-a-population-based-case-control-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology